| Metric | Q3 2026 | Q3 2025 |
|---|---|---|
| Revenue | 0.1 | 0.2 |
| Net income | 21.8 | 0.1 |
| EPS (diluted, $ a share) | $1.40 | $0.00 |
A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.
| Net income, year on year | +38107.0% |
|---|---|
| Revenue, year on year | -10.9% |
10-Q filed with the SEC, OTC: ISCO. Figures from the filing's XBRL data; summary written with AI assistance from the filing.
International Stem Cell Corp: key numbers
- Share price
- $0.1700Close, Nov 20
- Market cap
- $1.39M
- Shares outstanding
- 8.16MLatest SEC cover page
- Sector
- Life Sciences
- Industry
- Pharmaceutical PreparationsSIC 2834
Today's reference numbers, updated daily. Not a valuation or a recommendation.